Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tat Technologies (TATT) Research & Development (2018 - 2025)

Historic Research & Development for Tat Technologies (TATT) over the last 14 years, with Q3 2025 value amounting to $323000.0.

  • Tat Technologies' Research & Development fell 92.02% to $323000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 181.67%. This contributed to the annual value of $1.2 million for FY2024, which is 7454.55% up from last year.
  • Tat Technologies' Research & Development amounted to $323000.0 in Q3 2025, which was down 92.02% from $240000.0 recorded in Q2 2025.
  • In the past 5 years, Tat Technologies' Research & Development registered a high of $343000.0 during Q2 2024, and its lowest value of -$27000.0 during Q1 2022.
  • Over the past 5 years, Tat Technologies' median Research & Development value was $194000.0 (recorded in 2023), while the average stood at $202526.3.
  • As far as peak fluctuations go, Tat Technologies' Research & Development tumbled by 11985.29% in 2022, and later surged by 46666.67% in 2023.
  • Over the past 5 years, Tat Technologies' Research & Development (Quarter) stood at $149000.0 in 2021, then fell by 12.75% to $130000.0 in 2022, then surged by 103.85% to $265000.0 in 2023, then increased by 13.96% to $302000.0 in 2024, then grew by 6.95% to $323000.0 in 2025.
  • Its Research & Development stands at $323000.0 for Q3 2025, versus $240000.0 for Q2 2025 and $324000.0 for Q1 2025.